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Abstract
Percutaneous Transvenous Mitral Annuloplasty for mitral regurgitation is in early stages of 
development and involves a complex intervention which can not be done in patients with left 
ventricular leads. Since functional mitral regurgitation is common in low ejection fraction 
states,   we   propose   a   device   which   can   serve   for   annuloplasty   in   addition   to   cardiac 
resynchronization therapy and simplifying the intervention.
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Treatment of dilated cardiomyopathy has evolved considerably over years leading to marked 
improvement in quality of life and survival. This has been possible by intervening at the various 
biochemical, hemodynamic and electrical abnormalities by drugs and  use of  various devices. 
The role of cardiac resynchronization therapy (CRT) is an established one resulting in 
improvement in quality of life and survival and lately studies have shown  its benefit even in 
patients with  moderate fall in ejection fraction.                                          
One important accompaniment of dilated heart is functional mitral regurgitation secondary to 
mitral annular dilatation, apical displacement of papillary muscles and reduced transmitral 
closure force  secondary to LV systolic dysfunction.                                       
Cardiac resynchronization therapy helps by synchronizing the contractions of the postero-lateral 
wall and the interventricular septum and thereby improving the ejection fraction and by 
decreasing the functional mitral regurgitation by its presumed effect of synchronizing the 
motion of two papillary muscles and increasing transmitral closure force.                               
Percutaneous   transvenous mitral   annuloplasty (PTMA) for ischemic or functional mitral 
regurgitation is in its evolution. The procedure involves cannulation of coronary sinus via 
subclavian or internal jugular  vein and delivering  a hemispherical  structure from coronary 
sinus ostium posteriorly to the anerior interventricular branch of the   great cardiac vein 
anteriorly. As the coronary sinus  forms  the lateral half of the mitral annulus, the device alters  
the geometry of the mitral annulus  thereby causing better apposition of two valve cusps  and 
decreasing mitral regurgitation. Three such devices under investigation include Viacor PTMA 
device, CARILLON contour system and MONARC (previously VIKING) PTMA system all 
utilizing the various modifications of the same principle. These PTMA devices cannot be placed 
in patients who have coronary sinus leads of CRT devices. Since low ejection fraction states are 
usually associated with functional mitral regurgitation hence to produce a device which can 
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address both issues seems compelling.                                                                                   
Although the left ventricular leads of CRT devices are soft and may not significantly bring 
about conformational changes in the mitral annulus, part of reduction of mitral regurgitation can 
be expected by left ventricular lead especially once the lead is distally nicely fixed and under 
some tension. However  left ventricular lead is placed in the  lateral most  vein  which may 
include  only one fourth of the mitral annulus. If  left ventricular lead is modified in such a way 
that it is rendered  stiff in its distal part and part of the stiff end projects anteriorly upto anterior 
interventricular groove  it can serve as well for annuloplasty in addition to CRT. Otherwise a 
stiff  annuloplasty hemisphere can be delivered over the left ventricular lead hence simplifying 
the procedure and simultaneously addressing both issues.
 
Figure 1:  Proposed  left ventricular lead  bifurcating distally at 'd' into outer jacket  for annuloplasty  and core lead 
for CRT both having  separate stylets 'a' and 'b' for manipulation.'C' and  'e' show the cross sections  of lead at 
proximal   and   distal   ends   after   bifurcation.                                                                            
Figure  2:  After withdrawing   the stylet   'a' out of the annuloplasty lead, its distal end 'e'   takes predefined 
hemispherical shape which will help in scaffolding of mitral annulus improving  mitral leaflet coaptation  while 'c' 
the CRT lead is positioned in one of the lateral cardiac veins.                                                                     
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Figure 3:  After reaching the desired lateral cardiac vein 'e' in the coronary sinus 'd'  the CRT lead  'h' is directed 
across its ostium  to the tip while the annuloplasty jacket  lead  is pushed distally as far as possible  in the coronary 
sinus surrounding mitral valve annulus 'b'. 'c' coronary sinus ostium.'f'  left ventricular lead.                      
 
Figure 4: Final position of the bifurcated lead with annuloplasty part 'g' in the coronary sinus surrounding major 
part of mitral valve 'a' annulus 'b' and the CRT lead 'h' in the desired lateral  cardiac vein 'e'.The distal annuloplasty 
segment can be made of material that utilizes a slow conformational change because of delayed breakdown of 
biodegradeable polymer over 3 to 6 weeks resulting in further narrowing of mitral annulus.
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